FASPX
Price
$44.02
Change
+$0.54 (+1.24%)
Updated
Jun 6 closing price
Net Assets
1.65B
JVMCX
Price
$26.03
Change
+$0.25 (+0.97%)
Updated
Jun 6 closing price
Net Assets
21.45B
Interact to see
Advertisement

FASPX vs JVMCX

Header iconFASPX vs JVMCX Comparison
Open Charts FASPX vs JVMCXBanner chart's image
Fidelity Advisor Value Strategies M
Price$44.02
Change+$0.54 (+1.24%)
VolumeN/A
Net Assets1.65B
JHancock Disciplined Value Mid Cap C
Price$26.03
Change+$0.25 (+0.97%)
VolumeN/A
Net Assets21.45B
FASPX vs JVMCX Comparison Chart
Loading...
View a ticker or compare two or three
VS
FASPX vs. JVMCX commentary
Jun 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FASPX is a Buy and JVMCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
JVMCX has more cash in the bank: 21.5B vs. FASPX (1.65B). FASPX pays higher dividends than JVMCX: FASPX (0.43) vs JVMCX (0.00). FASPX was incepted earlier than JVMCX: FASPX (39 years) vs JVMCX (14 years). JVMCX (1.88) is less costly to investors than FASPX (1.34). FASPX is a more actively managed with annual turnover of: 61.00 vs. JVMCX (47.00). FASPX has a lower initial minimum investment than JVMCX: FASPX (0) vs JVMCX (1000). JVMCX annual gain was more profitable for investors over the last year : -4.66 vs. FASPX (-12.80). FASPX return over 5 years is better than : 48.62 vs. JVMCX (33.39).
FASPXJVMCXFASPX / JVMCX
Total Expense Ratio1.341.8772%
Annual Report Gross Expense Ratio1.341.8871%
Fund Existence39 years14 years-
Gain YTD-7.1141.897-375%
Front Load4%N/A-
Min. Initial Investment01000-
Min. Initial Investment IRAN/AN/A-
Net Assets1.65B21.5B8%
Annual Yield % from dividends0.430.00-
Returns for 1 year-12.80-4.66275%
Returns for 3 years-3.601.47-244%
Returns for 5 years48.6233.39146%
Returns for 10 years4.7425.9618%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
SBIO31.580.57
+1.84%
ALPS Medical Breakthroughs ETF
FTXL87.420.37
+0.43%
First Trust Nasdaq Semiconductor ETF
VUSB49.61-0.01
-0.02%
Vanguard Ultra-Short Bond ETF
XPP24.45-0.05
-0.22%
ProShares Ultra FTSE China 50
PCRB48.16-0.25
-0.52%
Putnam ESG Core Bond ETF